Haemonetics Corp. (HAE)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Haemonetics Corp. (HAE)
Company Performance

Current Price

as of Oct 16, 2024

$75.57

P/E Ratio

33.85

Market Cap

$3.87B

Description

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Metrics

Overview

  • HQBoston, MA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerHAE
  • Price$75.57+0.51%

Trading Information

  • Market Cap$3.87B
  • Float98.90%
  • Average Daily Volume (1m)566,448
  • Average Daily Volume (3m)584,189
  • EPS$2.26

Company

  • Revenue$1.33B
  • Rev Growth (1yr)7.98%
  • Net Income$38.37M
  • Gross Margin49.62%
  • EBITDA Margin21.87%
  • EBITDA$73.51M
  • EV$5.15B
  • EV/Revenue3.86
  • P/E33.85
  • P/S2.92
  • P/B4.27